Comparison of Safety of Sedatives Versus General Anesthesia in Laser Therapy for Retinopathy of Prematurity
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Laser therapy for retinopathy of prematurity (ROP) is commonly performed under general anesthesia (GA). However, the use of GA for laser therapy in neonates who have already undergone invasive ventilation may lead to postoperative complications such as severe apnea or the development of ventilator dependency. This study aimed to examine the safety of administering only sedatives instead of GA in extremely low birth weight (ELBW) infants, who are the usual recipients of laser therapy for ROP. Methods: Among ELBW infants who were admitted to the neonatal intensive care unit (NICU) at Samsung Medical Center between January and December 2012, we studied 30 patients treated with laser therapy for ROP. Results: The mean gestational age of the patients was 24.6±1.9 weeks, with a mean birth weight of 646±140 g. The mean age and weight of patients at the time of laser therapy for ROP was 36.3±2.3 weeks and 1,470±423 g. In terms of sedatives, 14 patients (46.7%) were administered chloral hydrate alone, 14 (46.7%) were administered a combination of chloral hydrate and midazolam, one was administered midazolam alone, and one received fentanyl. Prior to laser therapy, 16 patients (53.5%) had established self-respiration, 13 (43.3%) relied on non-invasive ventilation and one patient relied on invasive mechanical ventilation. Following laser therapy, two patients who initially had exhibited self-respiration required respiratory assistance via non-invasive positive pressure ventilation and no patient required intratracheal intubation. Conclusions: We conclude that the use of sedatives may be safe for ELBW infants who undergo laser therapy for ROP.
Abstract
Purpose: Laser therapy for retinopathy of prematurity (ROP) is commonly performed under general anesthesia (GA). However, the use of GA for laser therapy in neonates who have already undergone invasive ventilation may lead to postoperative complications such as severe apnea or the development of ventilator dependency. This study aimed to examine the safety of administering only sedatives instead of GA in extremely low birth weight (ELBW) infants, who are the usual recipients of laser therapy for ROP. Methods: Among ELBW infants who were admitted to the neonatal intensive care unit (NICU) at Samsung Medical Center between January and December 2012, we studied 30 patients treated with laser therapy for ROP. Results: The mean gestational age of the patients was 24.6±1.9 weeks, with a mean birth weight of 646±140 g. The mean age and weight of patients at the time of laser therapy for ROP was 36.3±2.3 weeks and 1,470±423 g. In terms of sedatives, 14 patients (46.7%) were administered chloral hydrate alone, 14 (46.7%) were administered a combination of chloral hydrate and midazolam, one was administered midazolam alone, and one received fentanyl. Prior to laser therapy, 16 patients (53.5%) had established self-respiration, 13 (43.3%) relied on non-invasive ventilation and one patient relied on invasive mechanical ventilation. Following laser therapy, two patients who initially had exhibited self-respiration required respiratory assistance via non-invasive positive pressure ventilation and no patient required intratracheal intubation. Conclusions: We conclude that the use of sedatives may be safe for ELBW infants who undergo laser therapy for ROP.
참고문헌 (26)
- Cayabyab R, "Retinopathy of prematurity:therapeutic strategies based on pathophysiology", Neonatology, 109, pp.369~376 (2016)
- Gibson DL, "Retinopathy of prematurity-induced blindness: birth weightspecific survival and the new epidemic", Pediatrics, 86, pp.405~412 (1990)
- Shah PK, "Retinopathy of prematurity: past, present and future", World J Clin Pediatr, 8, pp.35~46 (2016)
- Chen SD, "Variation in anaesthesia for the laser treatment of retinopathy of prematurity - a survey of ophthalmologists in the UK", Eye, 21, pp.1033~1036 (2007)
- Woodhead DD, "Avoiding endotracheal intubation of neonates undergoing laser surgery for retinopathy of prematurity", J Perinatol, 27, pp.209~213 (2007)
- Ehrenkranz RA, "Validation of the national institutes of health consensus definition of bronchopulmonary dysplasia", Pediatrics, 116, pp.1353~1360 (2005)
- Papile LA, "Incidence and evolution of subependymal and intraventricular hemorrhage:a study of infants with birth weights less than 1,500 gm", J Pediatr, 92, pp.529~534 (1978)
- Walsh MC, "Necrotizing enterocolitis:a practitioner's perspective", Pediatr Rev, 9, pp.219~226 (1988)
- Early Treatment for Retinopathy of Prematurity Cooperative Group, "Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial", Arch Ophthalmol, 121, pp.1684~1694 (2003)
- 공민귀, "Retinopathy of Prematurity in Infants Born before 25 Weeks Gestation in a Korean Single Neonatal Intensive Care Unit: Incidence, Natural History and Risk Factors", Journal of Korean Medical Science, 27(12), pp.1556~1562 (2012), 대한의학회
- Shin DH, "Risk factors and rate of progression for zone I versus zone II type 1 retinopathy of prematurity", J AAPOS, 18, pp.124~128 (2014)
- 최성호, "초극소저출생체중아와 극소저출생체중아의 미숙아망막병증 발생 빈도와 위험 인자에 관한 연구", 대한안과학회지, 47(6), pp.918~926 (2006), 대한안과학회
- Foroozan R, "Outcomes after laser therapy for threshold retinopathy of prematurity", Ophthalmology, 108, pp.1644~1646 (2001)
- Ng EY, "A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years:part 1: Visual function and structural outcome", Ophthalmology, 109, pp.928~935 (2002)
- Connolly BP, "A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years. Part 2: Refractive outcome", Ophthalmology, 109, pp.936~941 (2002)
- McLoone E, "Long term functional and structural outcomes of laser therapy for retinopathy of prematurity", Br J Ophthalmol, 90, pp.754~759 (2006)
- Haigh PM, "Retinopathy of prematurity: systemic complications associated with different anaesthetic techniques at treatment", Br J Ophthalmol, 81, pp.283~287 (1997)
- Sammartino M, "Efficacy and safety of continuous intravenous infusion of remifentanil in preterm infants undergoing laser therapy in retinopathy of prematurity: clinical experience", Paediatr Anaesth, 13, pp.596~602 (2003)
- Ulgey A, "Decreasing the need for mechanical ventilation after surgery for retinopathy of prematurity: sedoanalgesia vs. general anesthesia", Turk J Med Sci, 45, pp.1292~1299 (2015)
- Lönnqvist PA, "Successful use of laryngeal mask airway in lowweight expremature infants with bronchopulmonary dysplasia undergoing cryotherapy for retinopathy of the premature", Anesthesiology, 83, pp.422~424 (1995)
- Gunenc F, "Use of laryngeal mask airway in anesthesia for treatment of retinopathy of prematurity", Saudi Med J, 32, pp.1127~1132 (2011)
- Demirel N, "Remifentanil analgesia during laser treatment for retinopathy of prematurity: a practical approach in neonatal intensive care unit", Am J Perinatol, 31, pp.983~986 (2014)
- Kirwan C, "Morphine analgesia as an alternative to general anaesthesia during laser treatment of retinopathy of prematurity", Acta Ophthalmol Scand, 85, pp.644~647 (2007)
- Houston SK, "Laser treatment for retinopathy of prematurity", Laser Med Sci, 28, pp.683~692 (2013)
- Eipe N, "Anesthesia for laser treatment for retinopathy of prematurity-all clear now?", Paediatr Anaesth, 18, pp.1103~1105 (2008)
- Quinn GE, "Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4to 6 years of age", J AAPOS, 17, pp.124~128 (2013)